CDK14
Basic information
Region (hg38): 7:90466424-91210590
Previous symbols: [ "PFTK1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDK14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 23 | 1 | 2 |
Variants in CDK14
This is a list of pathogenic ClinVar variants found in the CDK14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-90469843-T-C | Likely benign (Oct 01, 2022) | |||
7-90709581-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
7-90726583-T-C | not specified | Uncertain significance (Oct 12, 2022) | ||
7-90726615-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
7-90726626-C-T | Benign (Jan 30, 2018) | |||
7-90726678-A-G | not specified | Uncertain significance (Feb 10, 2023) | ||
7-90726747-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
7-90726792-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
7-90726802-G-A | not specified | Uncertain significance (Apr 27, 2022) | ||
7-90747697-T-G | not specified | Uncertain significance (Feb 27, 2023) | ||
7-90747744-T-A | not specified | Uncertain significance (Jun 24, 2022) | ||
7-90863207-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
7-90863244-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
7-90917698-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
7-90955813-A-G | not specified | Uncertain significance (Oct 03, 2023) | ||
7-90984204-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
7-90984205-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
7-90984218-G-C | not specified | Uncertain significance (Mar 15, 2024) | ||
7-91079434-C-A | not specified | Uncertain significance (Nov 23, 2021) | ||
7-91079434-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
7-91079449-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
7-91079467-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
7-91112550-A-G | not specified | Uncertain significance (May 05, 2023) | ||
7-91112566-G-A | Benign (Jan 30, 2018) | |||
7-91112569-C-A | not specified | Uncertain significance (Mar 31, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDK14 | protein_coding | protein_coding | ENST00000265741 | 13 | 744168 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.50e-8 | 0.903 | 125723 | 0 | 25 | 125748 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.28 | 188 | 244 | 0.769 | 0.0000123 | 2948 |
Missense in Polyphen | 24 | 82.777 | 0.28993 | 1053 | ||
Synonymous | 0.0776 | 90 | 90.9 | 0.990 | 0.00000479 | 861 |
Loss of Function | 1.75 | 16 | 25.6 | 0.626 | 0.00000126 | 314 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000392 | 0.000392 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000978 | 0.0000967 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.000501 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport. {ECO:0000269|PubMed:16461467, ECO:0000269|PubMed:17517622, ECO:0000269|PubMed:19524571, ECO:0000269|PubMed:20059949}.;
- Pathway
- Transcriptional misregulation in cancer - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.366
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.41
Haploinsufficiency Scores
- pHI
- 0.458
- hipred
- Y
- hipred_score
- 0.792
- ghis
- 0.676
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdk14
- Phenotype
- skeleton phenotype;
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;protein phosphorylation;Wnt signaling pathway;cell division;regulation of cell cycle;regulation of canonical Wnt signaling pathway
- Cellular component
- cytoplasmic cyclin-dependent protein kinase holoenzyme complex;nucleus;cytoplasm;cytosol;plasma membrane
- Molecular function
- cyclin-dependent protein serine/threonine kinase activity;protein binding;ATP binding;cyclin binding